In a nutshell, our developed molecular probe 99mTc-PDA showed rapid blood clearance and good targeting in vivo and is expected to be a candidate drug for the SPECT/CT imaging of PD-L1 expression in cancer patients. This evidence concerns the gene CD274 and cancer.